Chris Collins

Managing Director
Healthcare Investment Banking

E-mail  |  Tel: +1 415 616-1609

Chris Collins

Chris Collins is a managing director in the Piper Jaffray healthcare investment banking group, covering biotechnology companies. He is based in the firm’s San Francisco office.

Prior to joining Piper Jaffray in June 2014, Collins was a senior calling officer in the global healthcare groups at Citigroup and Credit Suisse, where he focused on biotechnology companies. During his time at Citigroup and Credit Suisse, he successfully represented biotechnology clients in transactions with an aggregate transaction value exceeding $24 billion, including over $13 billion of M&A and over $11 billion of capital markets transactions. Prior to Citigroup and Credit Suisse, Collins was on the buy-side for more than eight years, more recently as a founder and portfolio manager at CPC Capital Management, a long/short healthcare-focused hedge fund. Before CPC Capital Management, he was an associate at Frazier Healthcare Ventures, a leading biotechnology venture capital firm with over $2 billion of assets under management. Collins helped start and invest in a number of successful biotechnology companies while a venture capitalist. Prior to Frazier Healthcare Ventures, he was an analyst in the global healthcare and leverage finance groups at Morgan Stanley.

Collins holds a bachelor’s degree in economics from Stanford University and a master’s degree in biotechnology from Johns Hopkins University. He is also a CFA® charterholder.